EverSource Wealth Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.7K | Buy |
7,490
+5,025
| +204% | +$58.2K | ﹤0.01% | 1280 |
|
|
2025
Q1 | $21.5K | Buy |
2,465
+2,291
| +1,317% | +$20K | ﹤0.01% | 1649 |
|
|
2024
Q4 | $2.5K | Sell |
174
-64
| -27% | -$919 | ﹤0.01% | 2631 |
|
|
2024
Q3 | $5.37K | Buy |
238
+99
| +71% | +$2.24K | ﹤0.01% | 2198 |
|
|
2024
Q2 | $2.87K | Buy |
139
+12
| +9% | +$248 | ﹤0.01% | 2427 |
|
|
2024
Q1 | $3.72K | Buy |
127
+73
| +135% | +$2.14K | ﹤0.01% | 2177 |
|
|
2023
Q4 | $3.02K | Buy |
54
+50
| +1,250% | +$2.8K | ﹤0.01% | 2050 |
|
|
2023
Q3 | $165 | Hold |
4
| – | – | ﹤0.01% | 2447 |
|
|
2023
Q2 | $223 | Buy |
+4
| New | +$223 | ﹤0.01% | 2417 |
|
|
2022
Q4 | – | Sell |
-31
| Closed | -$1K | – | 2435 |
|
|
2022
Q3 | $1K | Buy |
+31
| New | +$1K | ﹤0.01% | 1905 |
|